technetium tc 99m mertiatide has been researched along with Carcinoma, Squamous Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerretsen, M; Herscheid, JD; Snow, GB; van Dongen, G; Visser, GW | 1 |
Klok, R; Snow, GB; van der Schors, R; van Dongen, GA; van Gog, FB; Visser, GW | 1 |
2 other study(ies) available for technetium tc 99m mertiatide and Carcinoma, Squamous Cell
Article | Year |
---|---|
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Rhenium; Technetium Tc 99m Mertiatide | 1993 |
Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
Topics: Animals; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Mice; Mice, Nude; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Rhenium; Technetium Tc 99m Mertiatide; Tissue Distribution | 1996 |